Ambrisentan shortage: patients with pulmonary hypertension struggle

Supply shortages of ambrisentan, a vital drug for pulmonary hypertension, have persisted for months.

Published 21sem1 sourceNotableupdated 14sem
Lire en français
≈ 16s

The fact

Viatris laboratory limits distributions to hospital pharmacies and retail outlets.

Health authorities recommend therapeutic alternatives, but access remains unequal.

Click the link to read an article on the topic:
Explore this topic
What if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.
France · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →
Follow topic →
Auto-synthesis from 1 media source · identified on June 25, 2026
← Back to home
Discover

Read more

All sante →